您当前的位置:
首页 >
文章列表页 >
LIF-ting ferroptosis to improve liver cancer therapy
Discussion | 更新时间:2022-08-11
    • LIF-ting ferroptosis to improve liver cancer therapy

    • LIF-ting ferroptosis to improve liver cancer therapy

    • Genes & Diseases   2022年9卷第5期
    • 作者机构:

      1. Hubei Hongshan Laboratory, College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University,Hubei,Wuhan,PR China,430070

      2. Hubei Clinical Research Center for Precise Diagnosis and Treatment of Liver Cancer, Taihe Hospital, Hubei University of Medicine,Hubei,Shiyan,PR China,442000

      3. Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center,TX,Houston,USA,77030

      4. The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences,TX,Houston,USA,77030

    • DOI:10.1016/j.gendis.2022.02.013    

      中图分类号:
    • 纸质出版日期:2022,

      网络出版日期:2022-9-1,

    扫 描 看 全 文

  • Fan Yao, Yang Zhao, Li Ma. LIF-ting ferroptosis to improve liver cancer therapy[J]. Genes & Diseases, 2022,9(5). DOI: 10.1016/j.gendis.2022.02.013.

    Fan Yao, Yang Zhao, Li Ma. LIF-ting ferroptosis to improve liver cancer therapy[J]. Genes & Diseases, 2022,9(5). DOI: 10.1016/j.gendis.2022.02.013.

  •  
  •  
查看原文

0

浏览量

1

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0